These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39158195)

  • 41. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
    Peghin M; Russo A; Givone F; Ingani M; Graziano E; Bassetti M
    Infect Dis Ther; 2019 Dec; 8(4):695-702. PubMed ID: 31428940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs?
    Herrera-Hidalgo L; de Alarcón A; López-Cortes LE; Luque-Márquez R; López-Cortes LF; Gutiérrez-Valencia A; Gil-Navarro MV
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative activities of ampicillin and teicoplanin against Enterococcus faecalis isolates.
    Zacharopoulos GV; Manios GA; Papadakis M; Koumaki D; Maraki S; Kassotakis D; De Bree E; Manios A
    BMC Microbiol; 2023 Jan; 23(1):5. PubMed ID: 36609223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dalbavancin for infective endocarditis: a single centre experience.
    Durante-Mangoni E; Boccia F; Ursi MP; Karruli A; Andini R; Galdo M; Zampino R
    J Chemother; 2021 Jul; 33(4):256-262. PubMed ID: 33073724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.
    Partridge DG; O'Brien E; Chapman AL
    Postgrad Med J; 2012 Jul; 88(1041):377-81. PubMed ID: 22366395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enterococcal infective endocarditis is a marker of current occult or future incident colorectal neoplasia.
    Ursi MP; Bertolino L; Andini R; D'Amico F; Iossa D; Karruli A; D'Avenia E; Manduca S; Bernardo M; Zampino R; Durante-Mangoni E
    Eur J Intern Med; 2021 Jan; 83():68-73. PubMed ID: 33046347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy and safety of daptomycin in the treatment of gram-positive infective endocarditis: a meta-analysis].
    Ge Y; Zhou J; Ma XJ
    Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):205-214. PubMed ID: 36649992
    [No Abstract]   [Full Text] [Related]  

  • 49. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.
    Sullam PM; Täuber MG; Hackbarth CJ; Sande MA
    Antimicrob Agents Chemother; 1985 Jan; 27(1):135-6. PubMed ID: 3157344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
    Fantin B; Leclercq R; Arthur M; Duval J; Carbon C
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of surgery for extensive infective endocarditis.
    Huuskonen A; Kaarne M; Vento A; Juvonen T; Raivio P
    J Card Surg; 2021 Dec; 36(12):4675-4681. PubMed ID: 34547124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study.
    Pries-Heje MM; Hjulmand JG; Lenz IT; Hasselbalch RB; Povlsen JA; Ihlemann N; Køber N; Tofterup ML; Østergaard L; Dalsgaard M; Faurholt-Jepsen D; Wienberg M; Christiansen U; Bruun NE; Fosbøl E; Moser C; Iversen KK; Bundgaard H
    Eur Heart J; 2023 Dec; 44(48):5095-5106. PubMed ID: 37879115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A surveillance of high-level gentamicin-resistant enterococcal bacteremia.
    Araoka H; Kimura M; Yoneyama A
    Kansenshogaku Zasshi; 2012 Mar; 86(2 Suppl 4):27-8. PubMed ID: 23115941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections.
    Veve MP; Patel N; Smith ZA; Yeager SD; Wright LR; Shorman MA
    Int J Antimicrob Agents; 2020 Dec; 56(6):106210. PubMed ID: 33223119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis.
    Euba G; Lora-Tamayo J; Murillo O; Pedrero S; Cabo J; Verdaguer R; Ariza J
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4305-10. PubMed ID: 19667290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis.
    Briggs S; Broom M; Duffy E; Everts R; Everts G; Lowe B; McBride S; Bhally H
    J Antimicrob Chemother; 2021 Jul; 76(8):2168-2171. PubMed ID: 33975351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Enterococcal infective endocarditis: description of 12 cases].
    Martínez Odriozola P; Muñoz Sánchez J; Arriola Martínez P; Lizarralde Palacios E; Santamaría Jáuregui JM; Zuazo Meabe J; Cisterna Cáncer R; de la Villa FM
    An Med Interna; 2007 Nov; 24(11):539-42. PubMed ID: 18275263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Continuous Infusion Ampicillin for the Outpatient Management of Enterococcal Endocarditis: A Case Report and Literature Review.
    Lewis PO; Jones A; Amodei RJ; Youssef D
    J Pharm Pract; 2020 Jun; 33(3):392-394. PubMed ID: 30326771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients.
    Leport C; Perronne C; Massip P; Canton P; Leclercq P; Bernard E; Lutun P; Garaud JJ; Vilde JL
    Antimicrob Agents Chemother; 1989 Jun; 33(6):871-6. PubMed ID: 2527483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A surveillance of high-level gentamicin-resistant enterococcal bacteremia.
    Araoka H; Kimura M; Yoneyama A
    J Infect Chemother; 2011 Jun; 17(3):433-4. PubMed ID: 21042826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.